Expression of human telomerase reverse transcriptase and correlation with telomerase activity in placentas with and without intrauterine growth retardation

Acta Obstetricia et Gynecologica Scandinavica

Volumn 85, Issue 1, 2006, Pages 3-11

  Izutsu, Toshihiko ^a   Izutsu, Naoko ^a   Iwane, Ayako ^a   Takada, Anna ^a   Nagasawa, Takayuki ^a   Kanasugi, Tomonobu ^a   Sugiyama, Toru ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Chorionic villi; hTERT; IUGR; Placenta; Quantitative RT PCR; RT PCR; Telomerase activity

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; DNA BINDING PROTEIN; TELOMERASE;

ARTICLE; CHORION VILLUS SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; COMPARATIVE STUDY; FEMALE; METABOLISM; PREGNANCY;

CHORIONIC VILLI SAMPLING; DNA-BINDING PROTEINS; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PLACENTA; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE;

EID: 33645650674     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340500317096     Document Type: Article

References (54)

1. Blackburn EH. The molecular structure of centromeres and telomeres. Ann Rev Biochem. 1984;53:163.
2. Kim NW, Piatyszek MA, Prowse KR. Specific association of human telomerase activity, immortal cells and cancer. Science. 1994;266:2011-5.
3. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Human Genet. 1993;52(4):661-7.
4. Bacchetti S, Counter CM. Telomeres and telomerase in human cancer. Int J Oncol. 1995;7:423-32.
5. Kyo S, Kanaya T, Ishikawa H, Ueno H, Inoue M. Telomerase activity in gynecologic tumors. Clin Cancer Res. 1996;2:2023-8.
6. Shay JW, Gazdar AF. Telomerase in the early detection of cancer. J Clin Pathol 1997; 50: 106-9.
7. Zheng PS, Iwasaka T, Yamasaki F, Ouchida M, Yokoyama M, Nakao Y, et al. Telomerase activity in gynecologic tumors. Gynecol Oncol. 1997;64:171-5.
8. Hiyama K, Hirai Y, Koizumi S, Akiyama M, Hiyama E, Piatyszek MA, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol. 1995;155:3711-5.
9. Counter CM, Gupta J, Harley CB, Lever B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 1995;85:2315-20.
10. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA. 1996;93:6476-81.
11. Ramirez RD, Wright WE, Shay JW, Tayler RS. Telomerase activity concentrates in the active segments of human hair follicles. J Invest Dermatol. 1997;108:113-7.
12. Kyo S, Takakura M, Kohama T, Inoue M. Telomerase activity in human endometrium. Cancer Res. 1997;57:610-4.
13. Izutsu T, Kudo T, Sato T, Nishiya I, Ohyashiki K, Mori M, et al. Telomerase activity in human chorionic villi and placenta determined by TRAP and in situ TRAP assay. Placenta. 1998;19:613-8.
14. Izutsu T, Kudo T, Sato T, Nishiya I, Ohyashiki K, Nakagawara K. Telomerase activity and proliferative activity in placenta with or without fetal growth retardation. Obstet Gynecol. 1999;93(1):124-9.
15. Kyo S, Takakura M, Tanaka M, Kanaya T, Sagawa T, Kohama T, et al. Expression of telomerase activity in human chorion. Biochem Biophys Res Commun. 1997;241:498-503.
16. Nishi H, Oyashiki K, Fujito A, Yahata N, Oyashiki JH, Isaka K, et al. Comparison of telomerase activity in normal chorionic villi to trophoblastic diseases. Int J Oncol. 1998;12(1):81-5.
17. Feng J, Funk WD, Wang SS, Weinrich AAA, Chiu CP, Adams RR, et al. The RNA component of human telomerase. Science. 1995;269:1236-41.
18. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell. 1997;88:875-84.
19. Harrington L, Mcphail T, Mar V, Zhou W, Oulton R, Bass MB, et al. A mammalian telomerase associated protein. Science. 1997;275:973-7.
20. Nakamura TM, Morin GB, Chapman KB, Weinrech SL, Andrews WH, Lingner J, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science. 1997;277:955-9.
21. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, et al. hEST2, the putative human telomerase catalytic subunit gene is up-regulated in tumor cells and immortalization. Cell. 1997;90:785-95.
22. Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 1998;58:1558-61.
23. Kyo S, Kanaya T, Takakura M, Tanaka M, Inoue M. Human telomerase reverse transcriptase as a critical determination of telomerase activity in normal and malignant endometrial tissues. Int J Cancer. 1999;80:60-3.
24. Kyo S, Kanaya T, Takakura M, Tanaka M, Yamashita A, Inoue H, et al. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer. 1999;80:804-9.
25. Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, et al. Adenoviral expression of P53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res. 2000;6(4):1239-47.
26. Kudo T, Izutsu T, Sato T. Telomerase activity and apoptosis as indicators of ageing in placenta with and without intrauterine growth retardation. Placenta. 2000;21:493-500.
27. Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics. 1966;37:403-8.
28. Campbell S, Thomas A. Ultrasound measurement of the fetal head to abdomen circumference ratio in the assessment of growth retardation. Br J Obstet Gynec. 1977;84:165-74.
29. Benirschke K, Kaufmann P. Pathology of the Human Placenta, 3rd Edn. New York: Springer, 1995: 174-6.
30. Blackburn EH. Telomerases. Annu Rev Biochem. 1992;61:113-29.
31. Mantell LL, Greider CW. Telomerase activity in germline and embryonic cells of Xenopus. EMBO J. 1994;13:3211-7.
32. Conter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA. 1994;91:2900-4.
33. Schwartz HS, Juliao SF, Sciadini MF, Miller LK, Butler MG. Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer. 1995;75(5):1094-8.
34. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 1995;55:2533-6.
35. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity level with human neuroblastoma outcome. Nat Med. 1995a;1(3):249-55.
36. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, et al. Telomerase activity in small-cell and non-small cell lung cancers. J Natl Cancer Inst. 1995;87(12):895-902.
37. Langford LA, Piatyszek MA, Xu R, Schold SC, Shay JW. Telomerase activity in human brain tumors. Lancet. 1995;346:1267-8.
38. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Muarkami Y, et al. Telomerase activity in gastric cancer. Cancer Res. 1995;55:3258-62.
39. Tahara H, Nakanishi T, Kitamoto K, Nakashio R, Shay JW, Tahara E, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinoma. Cancer Res. 1995;55:2734-6.
40. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Taylor RS, et al. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res. 1996;56:218-22.
41. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst. 1996;88(2):116-22.
42. Chiu CP, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cell. 1996;14:239-48.
43. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol. 1996;106:759-65.
44. Hiyama E, Hiyama K, Tatsumoto N, Shay JW, Yokoyama T. Telomerase activity in human intestine. Int J Oncol. 1996;9:453-8.
45. Ohyashiki K, Ohyashiki JH, Nishimaki J, Toyama K, Ebihara Y, Kato H, et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res. 1997;57:2100-3.
46. Yahata N, Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Ando K, et al. Telomerase activity in lung cancer cells obtained from bronchial washings. J Natl Cancer Inst. 1998;90(9):684-90.
47. Kilian A, Bowtell DD, Abus HE, Hime GR, Venter DJ, Keese PK, et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet. 1997;6:2011-9.
48. Nishi H, Oyashiki K, Fujito A, Yahata N, Oyashiki JH, Isaka K, et al. Expression of telomerase subunits and localization of telomerase. Placenta. 1999;20:317-23.
49. Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC, Hoffman AR. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer. 2000;85(3):330-5.
50. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcript. Cancer Res. 1998;58:4168-72.
51. Espy MJ, Ross TK, Teo R, Svien KA, Wold AD, Uhl JR, et al. Evaluation of Light cycler PCR for implementation of laboratory diagnosis of Herpes Simplex Virus infections. J Clin Microbiol. 2000;38(8):3116-8.
52. Kassler HH, Muhbauer G, Rinner B, Stelzl E, Berger A, Dorr HW, et al. Detection of Herpes Simplex Virus DNA by Realtime PCR. J Clin Microbiol. 2000;38(7):2638-42.
53. Nakao M, Janssen JW, Flohr T, Bartram CR. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor by LightCycler technology. Cancer Res. 2000;60(12):3281-9.
54. Pfitzner T, Engert A, Wittor H, Schinkothe T, Oberhauser F, Schulz H, et al. A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia. Leukemia. 2000;14(4):754-66.